Profil
R.
Michael Floyd was the founder of Elion Oncology, Inc., founded in 2016, and held the titles of President, Chief Executive Officer & Director at the company.
Mr. Floyd is also the founder of BioAim LLC,Exbaq LLC..
Mr. Floyd was Chief Executive Officer-North America at EvoNext Holdings SA. Mr. Floyd was Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd completed undergraduate education at Georgetown University.
Anciens postes connus de R. Floyd
| Sociétés | Poste | Fin |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Directeur des opérations | 31/08/2023 |
BioAim LLC | Fondateur | - |
Exbaq LLC | Fondateur | - |
| EVONEXT HOLDINGS SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Fondateur | - |
Formation de R. Floyd
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolva Holding SA
Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Health Technology |
BioAim LLC | |
Exbaq LLC |
















